Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
2022 · The Journal of Prevention of Alzheimer s Disease · 1,228 citations
https://doi.org/10.14283/jpad.2022.30
Y
Y. Tian
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
1.3K
Citations
4
h-index
2
i10-index
Y. Tian is an academic researcher. The author has contributed to research in topics: Alzheimer's disease research and treatments & Cholinesterase and Neurodegenerative Diseases & Dementia and Cognitive Impairment Research. The author has an h-index of 4, co-authored 4 publications.
Papers by this author
worksInvestigating Partially Discordant Results in Phase 3 Studies of Aducanumab
2023 · The Journal of Prevention of Alzheimer s Disease · 22 citations
https://doi.org/10.14283/jpad.2023.6
Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease
2024 · The Journal of Prevention of Alzheimer s Disease · 8 citations
https://doi.org/10.14283/jpad.2024.106
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat